在结直肠癌中解码缺氧瘤微环境,用于预后建模和治疗点发现
Xiao-Cui Duan1, Yan Zhou2, Fan Feng2
1Department of Cell Biology, Institute of Basic Medicine, Hebei Medical University, Shijiazhuang, Hebei, China.
Frontiers in immunology
|September 11, 2025
概括
大肠直肠癌 (CRC) 中的缺氧驱动了进展. 我们确定了与缺氧相关的基因特征,预测了患者的预后,并发现GIPC2可能是治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物信息学是一种生物信息学.
背景情况:
- 缺氧是结直肠癌 (CRC) 瘤微环境 (TME) 的关键因素,影响恶性进展,化学抵抗和免疫逃避.
- 在CRC中缺氧反应的细胞异质性及其预后影响尚未完全理解.
研究的目的:
- 在CRC中使用单细胞RNA测序来划分缺氧和正常细胞种群.
- 确定缺氧相关基因 (HRG) 并开发基于缺氧的CRC预后特征.
- 为了研究GIPC2在CRC细胞中的功能作用.
主要方法:
- 来自15个CRC样本的集成单细胞RNA测序数据.
- 采用权重基因联合表达网络分析 (WGCNA),CellChat,SCENIC和GRNBoost2用于基因和通路分析.
- 使用癌症基因组图谱 (TCGA) 和GSE39582数据集开发和验证了八个基因的预后签名.
- 进行了体外测试,以评估GIPC2功能.
主要成果:
- 发现了八个不同的缺氧集群,其中H3集群显示高缺氧得分和糖蛋白代谢和血管生成途径的丰富.
- 八基因预后模型根据整体存活率将CRC患者显著分为高风险和低风险组.
- GIPC2的淘汰抑制了CRC细胞的增殖,迁移和入侵,同时诱导了细胞亡和逆转了表皮-介质细胞转换 (EMT) 现型.
结论:
- 一个强大的缺氧相关的基因特征准确地预测结直肠癌患者的预后.
- GIPC2被确定为潜在的生物标志物和低氧驱动的CRC的治疗标.
- 研究结果为CRC生物学和个性化治疗策略提供了新的见解.
更多相关视频
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
11.8K
08:42Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
2.1K
相关概念视频
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K